Navigation Links
Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
Date:2/7/2008

involve risks and uncertainties. These statements include those relating to: our ability to close the financing transaction, early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-KSB and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio
2. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
3. Access Pharmaceuticals Announces $2.7 Million New Equity
4. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
5. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
6. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
7. Access Pharmaceuticals Announces $19.5 Million Recapitalization
8. Access Genetics Announces New Executive Appointments
9. Pharmasset Accesses up to $30 Million of Working Capital
10. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
11. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The Medical Innovation Impact Index (MI3), a new ... innovation, has been developed at the Initiative for ... ( FDU ) Rothman Institute of Innovation and Entrepreneurship. ... FDA (Food & Drug Administration) draft guidance documents and ... medical devices. , “The main impediment to innovation ...
(Date:5/26/2015)... May 26, 2015 The University ... the Max Planck Society establishing the Max ... The center will link two of the world's foremost ... be only the third Max Planck Centre in North ... society for optics and photonics, was with university ...
(Date:5/26/2015)... GERMANY (PRWEB) May 26, 2015 ... R. Grace & Co. (NYSE: GRA) announces that ... good manufacturing practice (GMP) certification from EXCiPACT™, an ... of pharmaceutical excipients. , All three ... of pharmaceutical grade excipient silica gels have now ...
(Date:5/26/2015)... HILDEN, Deutschland, May 26, 2015 ... ®   ermöglicht klinischen Laboren ... dazugehöriger Berichte; Vorstellung auf den Konferenzen ClinGen, ... N.V. (NASDAQ: QGEN ; Frankfurt Prime ... QIAGEN Clinical Insight ® (QCI™) bekannt. ...
Breaking Biology Technology:Medical Innovation Impact Index Launched at Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) under the Rothman Institute 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6
... Virginia Key, Fla. Climate models have long predicted ... precipitation events. A new study conducted at the University ... the first observational evidence to confirm the link between ... One of the most serious challenges humanity will face ...
... DIEGO, Aug. 7 SGX Pharmaceuticals,(Nasdaq: SGXP ) today ... June 30, 2008. For the three months ended June 30, ... loss of $7.2 million. For,the six months ended June 30, ... million. The revenue in the six month period includes $10.8,million ...
... (Nasdaq: ISTA ), today reported financial results for the ... $17.8 million for the,quarter ended June 30, 2008, a 31% ... the second quarter ended June 30, 2008, was $8.5 million,(or ... $8.7 million (or $0.32,per share) for the same period in ...
Cached Biology Technology:Climate change: When it rains it (really) pours 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 4SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 5SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 6SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 7SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 8SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 9ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 2ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 3ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 4ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 5ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 6ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results 7
(Date:5/7/2015)... 2015 Fingerprint Cards (FPC) ... FPC1035, FPC,s smallest touch fingerprint sensors to date.  ... for integration on the backside of the phone, ... possibilities to integrate touch fingerprint sensors in the ... possibilities for module manufacturers to customize the look ...
(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... study that looked at consumers who buy locally ... community-supported agriculture programs found the venues largely attract ... findings present a need for broadening local food ... payment plans and strategic efforts that make fresh ...
... are linked to one of the most lethal forms of ... of the genes found in the study are frequently altered ... of tumors. The findings appear in the Oct. 28, 2012, ... was led by researchers from the National Human Genome Research ...
... SAN FRANCISCO, CAOctober 28, 2012 Scientists at the Gladstone ... discovered how modifying a gene halts the toxic buildup ... point to a potential new tactic for treating a ... or Lou Gehrig,s disease)a fatal disease for which there ...
Cached Biology News:Greater effort needed to move local, fresh foods beyond 'privileged' consumers 2NIH researchers identify novel genes that may drive rare, aggressive form of uterine cancer 2NIH researchers identify novel genes that may drive rare, aggressive form of uterine cancer 3NIH researchers identify novel genes that may drive rare, aggressive form of uterine cancer 4Gladstone, Stanford scientists block toxic protein that plays key role in Lou Gehrig's disease 2Gladstone, Stanford scientists block toxic protein that plays key role in Lou Gehrig's disease 3
Selective media for Salmonella...
... can be used as a fully functional, ... Software provides the means to record and ... These data can then be copied and ... Microsoft Excel or Lotus 123, or into ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
... Yeast Oligo Microarray Kit (V2), 2 ... simultaneously characterize expression of many thousands ... activity during important biological processes. Each ... 6,256 known ORFs from the S288C ...
Biology Products: